# NIH Awards EV2 $2.1M Device Grant

The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded EV2 Technologies a two-year, $2.1 million SBIR Direct-to-Phase II grant to advance Biocarpet, a biodegradable endovascular device for peripheral artery disease. The funded work includes manufacturing scale-up, redesign of the delivery catheter and control console, prototype and benchtop testing, and a six-month animal study; the award also supports licensing University of Pittsburgh technology. This is a completed award, not an open solicitation.

- **Why this matters:** The award signals federal R&D investment in early-stage vascular-device development and identifies manufacturing scale-up, catheter and console development, and preclinical testing as funded work areas.
- Medtech contractors and suppliers can use the award scope to understand the technical capabilities supporting this NIH-backed development effort, but the signals identify no current procurement or subcontract opportunity.
- Organizations pursuing NIH-funded medical-device work can note the SBIR Direct-to-Phase II mechanism and the role of university-developed technology in this award.

**Jurisdictions:** federal
**Industries:** Healthcare
**Topics:** Grants & Funding
**Published:** November 20, 2026

### Government Entities
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)

### Vendors
- EV2 Technologies (awardee)

### Key Quotes
> Given the nature of our work, we're pursuing a hybrid approach between private and federal fundraising
> — Ali Behrangzade, Chief Executive Officer

### Sources
- [EV2 Technologies Secures NIH Award to Advance Biodegradable Stent](https://bioengineer.org/ev2-technologies-secures-nih-award-to-advance-biodegradable-stent-alternative) - Bioengineer.org
- [EV2 lands $2.1M NIH grant for biodegradable artery device | Dealroom.co](https://app.dealroom.co/news/note/ev2-lands-2-1m-nih-grant-for-biodegradable-artery-device) - Dealroom